Skip to main content

Table 3 IMP diagnoses were highly associated with real-world decisions

From: Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort

Association Univariate analysis Multivariate analysis
  OR (95 % CI) p value OR (95 % CI) p value
Real-world decision (intervention vs. surveillance) at follow-up
Initial ICG recommendation 5.6 (3.7 − 8.5) <0.0001 3.7 (2.4 − 5.8) <0.0001
Initial IMP diagnosis 16.8 (9.0 − 34.4) <0.0001 11.4 (6.0 − 23.7) <0.0001
Actual patient outcome (benign vs. malignant) at follow-up
Initial ICG recommendation 8.5 (3.9 − 22.3) <0.0001 2.5 (1.0 − 7.4) 0.066
Initial IMP diagnosis 47.4 (23.8 − 102.4) <0.0001 35.8 (17.4 − 80.0) <0.0001
  1. Univariate and multivariate analyses indicated that IMP diagnoses were highly associated with real-world intervention and surveillance decisions and predictive of actual patient outcomes